Skip to main content
Dryad

Establishment of patient-derived xenotransplant and cell line models for canine B-cell lymphoma

Data files

Sep 16, 2026 version files 6.04 KB

Click names to download individual files

Abstract

High grade canine B-cell lymphoma (cBCL) is a spontaneous cancer in dogs with a very similar pathology to human diffuse large B-cell lymphoma (DLBCL). The value of comparative oncology to both dogs and humans has long been recognized, but the progress in cBCL research has been hampered by a scarcity of preclinical models. This study aimed to establish and characterize novel patient-derived xenograft (PDX) and cell line models from primary cBCL tumors to address this critical gap. To this end, primary cBCL tumors from three canine patients were surgically excised and serially transplanted into immunodeficient NOD scid gamma (NSG) mice. The resulting PDX models were characterized across passages using histology, flow cytometry, SNP genotyping, and RNA sequencing, the results of which show that they retain much of their original characteristics, even after multiple NSG passages. Cancer cells from two of the PDX lines were successfully adapted to in vitro culture, creating two new established cell lines, one of which was then used in drug sensitivity assays. The successful generation and characterization of these cBCL PDX and cell lines provides a valuable resource in canine cancer research.